Velarion Records
Free. Unsubscribe any time.

Contineum Therapeutics, Inc. (CTNM)

Contineum Therapeutics, Inc. filed 21 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 30 transactions and 122,299 shares. None carries the SEC's AFF10B5ONE flag; all 21 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Contineum Therapeutics, Inc. 30

Adoption dates in Contineum Therapeutics, Inc. 1

Results prints in Contineum Therapeutics, Inc. 0

Trades before a print in Contineum Therapeutics, Inc. 0

Interval to Contineum Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Contineum Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on September 23, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.